Next Article in Journal
RhoB: Team Oncogene or Team Tumor Suppressor?
Next Article in Special Issue
The Pleiotropic Effects of the Canonical Wnt Pathway in Early Development and Pluripotency
Previous Article in Journal
lncRNA Gene Signatures for Prediction of Breast Cancer Intrinsic Subtypes and Prognosis
Previous Article in Special Issue
Renal Tubule Repair: Is Wnt/β-Catenin a Friend or Foe?
Article Menu
Issue 2 (February) cover image

Export Article

Open AccessArticle
Genes 2018, 9(2), 66; https://doi.org/10.3390/genes9020066

WNT9A Is a Conserved Regulator of Hematopoietic Stem and Progenitor Cell Development

1
Department of Cellular and Molecular Medicine, University of California, San Diego, CA 92037, USA
2
Murdoch Childrens Research Institute, The Royal Children’s Hospital, Parkville, VIC 3052, Australia
3
Department of Anatomy and Developmental Biology, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC 3800, Australia
4
Department of Paediatrics, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC 3052, Australia
*
Authors to whom correspondence should be addressed.
Received: 30 November 2017 / Revised: 10 January 2018 / Accepted: 23 January 2018 / Published: 29 January 2018
(This article belongs to the Special Issue Wnt Signaling in Stem Cells)
View Full-Text   |   Download PDF [2420 KB, uploaded 29 January 2018]   |  

Abstract

Hematopoietic stem cells (HSCs) differentiate into all cell types of the blood and can be used therapeutically to treat hematopoietic cancers and disorders. Despite decades of research, it is not yet possible to derive therapy-grade HSCs from pluripotent precursors. Analysis of HSC development in model organisms has identified some of the molecular cues that are necessary to instruct hematopoiesis in vivo, including Wnt9A, which is required during an early time window in zebrafish development. Although bona fide HSCs cannot be derived in vitro, it is possible to model human hematopoietic progenitor development by differentiating human pluripotent stem cells to hematopoietic cells. Herein, we modulate WNT9A expression during the in vitro differentiation of human embryonic stem cells to hematopoietic progenitor cells and demonstrate that WNT9A also regulates human hematopoietic progenitor cell development in vitro. Overexpression of WNT9A only impacts differentiation to CD34+/CD45+ cells during early time windows and does so in a dose-dependent manner. The cells that receive the Wnt signal—not the cells that secrete WNT9A—differentiate most efficiently to hematopoietic progenitors; this mimics the paracrine action of Wnt9a during in vivo hematopoiesis. Taken together, these data indicate that WNT9A is a conserved regulator of zebrafish and human hematopoietic development. View Full-Text
Keywords: hematopoiesis; hematopoietic stem cells; Wnt signaling; WNT9A; human embryonic stem cells; induced pluripotent stem cells hematopoiesis; hematopoietic stem cells; Wnt signaling; WNT9A; human embryonic stem cells; induced pluripotent stem cells
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Richter, J.; Stanley, E.G.; Ng, E.S.; Elefanty, A.G.; Traver, D.; Willert, K. WNT9A Is a Conserved Regulator of Hematopoietic Stem and Progenitor Cell Development. Genes 2018, 9, 66.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Genes EISSN 2073-4425 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top